MARASTONI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 9.341
AS - Asia 4.523
EU - Europa 2.178
SA - Sud America 690
AF - Africa 84
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.835
Nazione #
US - Stati Uniti d'America 9.184
SG - Singapore 1.678
CN - Cina 1.184
BR - Brasile 548
UA - Ucraina 520
VN - Vietnam 463
HK - Hong Kong 389
DE - Germania 366
TR - Turchia 358
GB - Regno Unito 297
IT - Italia 168
PL - Polonia 163
FR - Francia 161
FI - Finlandia 151
SE - Svezia 123
RU - Federazione Russa 94
JP - Giappone 92
MX - Messico 83
IN - India 77
CA - Canada 52
AR - Argentina 45
BD - Bangladesh 42
ZA - Sudafrica 39
ID - Indonesia 38
BE - Belgio 34
IQ - Iraq 34
CO - Colombia 27
NL - Olanda 25
PK - Pakistan 25
ES - Italia 22
CL - Cile 20
UZ - Uzbekistan 17
EC - Ecuador 16
AU - Australia 14
MY - Malesia 14
VE - Venezuela 14
PH - Filippine 13
SA - Arabia Saudita 13
AE - Emirati Arabi Uniti 10
IR - Iran 10
LT - Lituania 10
MA - Marocco 10
JO - Giordania 9
NP - Nepal 8
KR - Corea 7
RO - Romania 7
TN - Tunisia 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
JM - Giamaica 6
PE - Perù 6
KE - Kenya 5
OM - Oman 5
PY - Paraguay 5
TH - Thailandia 5
AT - Austria 4
CH - Svizzera 4
EG - Egitto 4
KG - Kirghizistan 4
TW - Taiwan 4
EE - Estonia 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
PA - Panama 3
QA - Qatar 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
LK - Sri Lanka 2
LY - Libia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TJ - Tagikistan 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GM - Gambi 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 16.821
Città #
Singapore 1.076
Ashburn 985
Woodbridge 897
Fairfield 876
Houston 582
Jacksonville 564
Ann Arbor 502
San Jose 474
Chandler 433
Santa Clara 387
Hong Kong 381
Beijing 372
Seattle 336
Wilmington 310
Dallas 296
Cambridge 252
Izmir 174
Nanjing 170
Ho Chi Minh City 163
Warsaw 158
Dearborn 127
Hanoi 121
Los Angeles 117
Princeton 107
San Diego 104
Lauterbourg 90
Tokyo 90
Boardman 74
New York 72
Addison 68
São Paulo 67
Mexico City 58
Milan 50
Munich 49
Shenyang 48
Hefei 46
Nanchang 44
Shanghai 38
Ferrara 37
Brooklyn 35
Council Bluffs 35
Hebei 35
Brussels 34
Helsinki 30
Jiaxing 29
London 29
Washington 28
Da Nang 27
Tianjin 27
Chicago 26
Jinan 23
San Mateo 23
Falkenstein 22
San Francisco 22
Auburn Hills 21
Porto Alegre 21
Rio de Janeiro 21
Turku 21
Bremen 19
Changsha 19
Haiphong 19
Baghdad 18
Buffalo 18
Frankfurt am Main 18
Johannesburg 18
Kunming 18
Orem 18
Phoenix 18
Mountain View 16
Zhengzhou 16
Boston 15
Chennai 15
Jakarta 15
Moscow 15
Stockholm 15
Toronto 15
Manchester 14
Montreal 14
Poplar 13
Tashkent 13
Falls Church 12
Guangzhou 12
Norwalk 12
Denver 11
Ningbo 11
Amsterdam 10
Atlanta 10
Belo Horizonte 10
Brasília 10
Dong Ket 10
Hải Dương 10
Philadelphia 10
The Dalles 10
Des Moines 9
Indiana 9
Redwood City 9
Columbus 8
Dhaka 8
Istanbul 8
Lahore 8
Totale 11.860
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 399
A cyclic peptide T analogue with high chemotactic activity 283
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 254
Arecoline tripeptide inhibitors of proteasome 246
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 242
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 221
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 219
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 216
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 214
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 212
Vinyl ester-based cyclic peptide proteasome inhibitors 211
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 211
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 208
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells 202
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 202
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 199
A 500 MHz study of peptide T in a DMSO solution 199
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 197
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 197
A Bioactive Fullerene Peptide 195
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 194
Conformational analysis of peptide T and of its C‐pentapeptide fragment 189
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 188
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 188
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 187
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 185
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 184
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 180
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 180
Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6 179
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 179
Structure–activity relationships of cyclic and linear peptide T analogues 178
Synthesis and biological activity of carboxyl terminally extended dermorphins 173
Amygdalin binds to the CD4 receptor as suggested from molecular modeling studies 173
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 172
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 171
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 170
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 170
Anodic mineralization of pentachlorophenol in alkaline media 169
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 166
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 165
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 165
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 164
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 161
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 158
Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity 157
Opioid peptides Synthesis and binding properties of dermorphin related heptapeptides 156
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 155
Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors 152
Reversed-phase HPLC study on the in vitro enzymic degradation of dermorphin 151
Synthesis and Opioid Activity of Dermorphin Tetrapeptides Bearing D-Methionine S-Oxide at Position 2 151
Conformational properties of deltorphin: new features of the delta-opioid receptors 150
Synthetic tetrapeptides related to dermorphin: Potent long lasting analgesic action following subcutaneous administration 150
New cyclic peptide proteasome inhibitors 150
Synthesis and Opioid Activity of [sar4]dermorphin-Tetrapeptide Analogues 149
Direct electro-oxidation of bisphenol-A in aqueous alkaline media 149
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 145
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 145
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors 144
Synthesis and activity of dermorphine growth hormone releasing factor hybrid peptides 142
Synthesis and structure activity relationships of delthorphine analogues 140
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 140
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 139
analisi volumetricaper precipitazione, chelometria ed ossidoriduzione 138
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues 137
Ammino Acidi Conformazionalmente Vincolati: Sintesi di un Analogo della Metionina 136
Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope 136
In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans 135
Opioid peptides. Biological study of (D-Meto2) dermorphin analogues in relation to the plurality of opioid receptors 130
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 128
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals 128
Opioid peptides. Partially modified retro-inverso dermorphin analogues 128
Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit 126
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides 125
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)-tartaric acid 124
Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors 122
Dehydro‐dermorphins: I. Influence of the stereo‐orientation of aromatic groups in dermorphin‐(1–5)‐peptides to opioid activity 122
New features of the δ opioid receptor: Conformational properties of deltorphin I analogues 121
Analisi volumetrica per precipitazione, chelometria ed ossidoriduzione 120
Peptide-based molecules for the production of positive charged liposomes and micelles 118
Dehydro‐dermorphins: II. Synthesis and biological activity of unsaturated dermorphin hexa and heptapeptides 118
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans 117
Synthesis and biological activity of chelator-peptide T conjugates 116
Synthesis and activity of new linear and cyclic peptide T derivatives 115
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure 115
New insights on μ/δ selectivity of opioid peptides: Conformational analysis of deltorphin analogues 115
Effects of peptide T derivatives on the proliferation of cultured human keratinocytes. 114
Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8 112
null 107
Synthesis and biological activity of D-glucopyranosyl peptide T derivatives 107
Structure-activity relationships of peptide T-related pentapeptides 107
null 107
C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors 106
Studies of anti-phospholipase A2 and anti-inflammatory activites of a synthetic nonapeptide from uteroglobin 105
Structure-activity relationships of dermorphin tetrapeptides carrying a ketomethylene linkage 101
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TO PENTAPEPTIDE ANALOG DERIVED FROM IMMUNODEFICIENCY VIRUS PROTEIN gp120 101
Opioid peptides. Synthesis and biological properties of dermorphin, related hexapeptides 99
Synthesis and antiaggregatory activity of antiflammin related peptides 98
null 96
Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides 95
Totale 15.905
Categoria #
all - tutte 70.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.184
Totale 71.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021439 0 0 0 0 0 0 0 0 0 181 189 69
2021/20221.267 44 91 77 89 110 43 55 75 47 81 86 469
2022/20231.009 121 41 31 123 176 165 41 89 132 5 49 36
2023/2024565 47 76 50 13 62 131 17 28 3 5 10 123
2024/20251.851 41 31 145 54 288 155 12 129 307 199 304 186
2025/20265.655 652 290 733 745 772 363 649 278 537 636 0 0
Totale 16.940